Drawing for SYNTERACT

USPTO serial 90504612

SYNTERACT

Reviewed by CopyMark Law Group

Reg. 6595078Status 700Renewal
Filing date
Status date
Registration date
Dec 21, 2021
Examiner
KING, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SYNTERACT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael A. Geller

MICHAEL A. GELLER DLA PIPER LLP (US)P.O. BOX 64807CHICAGO, IL 60664-0807UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Strategic business consulting in the pharmaceutical, biotechnology and life sciences fields; business monitoring and consulting services, namely, the use of data analytics in the fields of pharmaceuticals, biotechnology and life sciences; business consulting in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; business project management services in the fields of pharmaceuticals, biotechnology and life sciences; business risk management in the fields of pharmaceuticals, biotechnology and life sciencesACTIVEMar 3, 1994

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 11, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 4, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 15, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 21, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 5, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 5, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 15, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 2, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 2, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 2, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 2, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 2, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 24, 2021DOCKASSIGNED TO EXAMINER—
May 19, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 5, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance